Structured Summary
Abstract
A tyrosine kinase receptor inhibitor that targets mutants of PROTO-ONCOGENE PROTEIN KIT and PLATELET-DERIVED GROWTH FACTOR ALPHA RECEPTOR.
MeSH Record
Classification
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
Drug Class
Pharmacological Action
MeSH Record
Synonyms
4 entry terms
- (1S)-1-(4-Fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo(2,1-f)(1,2,4)triazin-4-yl)-1-piperazinyl)-5-pyrimidinyl)ethanamine
- 5-Pyrimidinemethanamine, alpha-(4-fluorophenyl)-alpha-methyl-2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo(2,1-f)(1,2,4)triazin-4-yl)-1-piperazinyl)-, (alphaS)-
- Ayvakit
- BLU-285
MeSH Record
Aspects Covered
25 allowable subheadings
Indexed with the subheadings administration & dosage, adverse effects, agonists, analogs & derivatives, analysis, antagonists & inhibitors, blood, cerebrospinal fluid, chemical synthesis, chemistry, classification, economics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, poisoning, radiation effects, standards, supply & distribution, therapeutic use, toxicity, urine.
MeSH Record
History Note
2026 (2020)
MeSH Hierarchy
Tree Numbers
AMA Style
References
- National Library of Medicine. Avapritinib. Medical Subject Headings (MeSH). 2026. Unique ID D000099289. http://id.nlm.nih.gov/mesh/2026/D000099289